sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Stake in Mural Oncology
The Vanguard Group, Inc. has filed a Form 8.3 with the Irish Takeover Panel regarding its interest in Mural Oncology plc, as of September 9, 2025. Under the requirements of the Irish Takeover Panel Act, Vanguard disclosed holding 771,283 ordinary shares, equating to a 4.47% stake in the company. No options or derivatives are reported in this disclosure.
No purchases or sales in cash-settled and stock-settled derivatives have been performed. A small sale of 48 ordinary shares occurred at $2.08 USD per unit. The filing indicates no indemnity or other arrangements regarding the relevant securities and no external agreements concerning options or derivatives.
This disclosure comes under Rule 8.3, acknowledging Vanguard's significant interest, which exceeds the 1% threshold, thereby triggering mandatory reporting. No additional parties are disclosed in connection with this stake.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.